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See related article on page 433.doi:10.1016/j.jtcvs.2005.03.037The report by Yoshimasu and associates1 is an analysis of 58 patients, selectedfrom a pool of 308, who underwent surgical intervention for primary lungcancer at their university. As an alternative to complete mediastinal lymph-
adenectomy at the time of pulmonary resection, they sampled one lymph node from
each of three stations. They justify this partial dissection by citing a previous study
that showed this method to be 94.5% accurate. The authors conclude that this
limited dissection of the three stations “seems more practical and convenient” than
sentinel lymph node mapping. Additionally, they conclude their findings validate
limited mediastinal lymph node dissection.
Because the American College of Surgeons Oncology Group (ACOSOG) Z0030
study, a randomized trial that looked at more than 1000 patients and compared
lymph node sampling with lymph node dissection, found no increase in morbidity
or mortality from lymph node dissection, there seems little benefit to limiting a
mediastinal lymph node dissection.2 The status of thoracic lymph nodes is the main
determinant of outcome for a patient with a resectable lung cancer. Without lymph
node involvement, cure rates of 70% to 90% can be expected. With lymph node
involvement limited to the N1 lymph nodes, a 40% to 50% 5-year survival can be
expected. Unfortunately, N2 lymph node involvement portends a poor 5-year
survival. Thus accurate mediastinal nodal staging is critical to predicting long-term
survival. Furthermore, with the recent finding that patients with N1 or N2 involve-
ment are helped by postoperative chemotherapy, incomplete or inaccurate nodal
staging could potentially prevent some patients from receiving beneficial postoper-
ative chemotherapy.3
Removing a few lymph nodes from selected nodal stations on the basis of what
lobe the cancer is in adds confusion and complicates an operation. Because there is
not an increased risk of complications from a mediastinal nodal dissection, all of the
mediastinal lymph nodes should be removed.
As thoracic surgeons specializing in lung cancer treatment, we should encourage
complete lymph node resection during pulmonary resections for lung cancer. The
disturbing report by Little4 presented at the recent Society of Thoracic Surgeons
meeting in January of 2005 highlights the need for change. He reviewed the pattern
of surgical care in more than 11,000 patients with lung cancer. Analysis revealed
that only 34% of patients had any lymph node biopsy. That is not a typographical
error. No lymph nodes were sampled in 66% of patients undergoing pulmonary
resection for lung cancer! Before we try to decide whether we should sample three
stations, do a sentinal lymph node dissection, or do some other limited resection, we
should encourage surgeons to be sure that all patients surgically treated for lung
cancer have at least some lymph nodes examined. Whether a complete mediastinal
lymphadenectomy will improve long-term survival awaits the result of the
ACOSOG multicenter trial. This will likely take 4 to 5 years, while follow-up
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Lmatures. In the meantime, patients deserve to have lymph
nodes removed to obtain an accurate diagnosis and poten-
tially higher cure rates.
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